Microorganism delivery of cancer vaccines

Area of Science:

• Oncology
• Immunology
• Microbiology
• Biotechnology

Background:

• Cancer immunotherapies, including vaccines, aim to harness the immune system to eliminate cancer cells.
• Current challenges in cancer vaccines include the immunosuppressive tumor microenvironment, tumor heterogeneity, and inefficient delivery.
• Microbe-based vaccines are emerging as a novel strategy to overcome these limitations.

Purpose of the Study:

• To review the interactions between microorganisms and the host immune system in the context of cancer therapy.
• To systematically introduce the tumor-targeting mechanisms of microbial agents.
• To comprehensively describe the advantages, applications, and challenges of bacteria and viruses as cancer vaccines.

Main Methods:

• Literature review focusing on microbial cancer vaccines, including bacterial and viral strategies.
• Analysis of synthetic biology applications for enhancing microbial vaccine efficacy.
• Exploration of combination therapies involving microbial vaccines.

Main Results:

• Microorganisms, particularly bacteria and viruses, can target hypoxic tumor regions and enhance tumor microenvironment immunogenicity.
• Synthetic biology allows for precise antigen or immune checkpoint inhibitor expression in microbial vaccines, enabling personalized approaches.
• Combination therapies show potential for improved antitumor outcomes.

Conclusions:

• Microbe-based cancer vaccines represent a transformative immunotherapy strategy with significant tumor-targeting and immune-activating potential.
• Further research is needed to address the challenges associated with microbial cancer vaccines for clinical translation.
• Microbial vaccines hold promise for revolutionizing cancer vaccine design and personalized immunotherapy.